Skip to main content
. 2015 Dec 30;37(2):139–144. doi: 10.1093/carcin/bgv248

Table 1.

Description of exome sequencing validation sample

Variable Lung cancer cases with emphysema (n = 267) Lung cancer cases without emphysema (n = 345) P homogeneity
Sex (n, %)
 Male 78 (29.2) 111 (32.2) 0.432
 Female 189 (70.8) 234 (67.8)
Race (n, %)
 White 127 (47.6) 133 (38.6) 0.025
 Black 140 (52.4) 212 (61.4)
Age (mean, SD) 61.8 (9.7) 58.7 (11.1) <0.001
Emphysema (n, %)
 No 0 345 (100.0)
 Yes 267 (100.0) 0
Education years (mean, SD) 12.0 (2.3) 12.7 (2.6) <0.001
Family history of lung cancer (n, %)
 No 219 (82.0) 275 (79.7) 0.472
 Yes 48 (18.0) 70 (20.3)
Smoking status (n, %)
 Never 0 (0.0) 29 (8.4) <0.001
 Ever 267 (100.0) 316 (91.6)
Packyears (smokers only) (mean, SD) 48.1 (27.1) 40.0 (27.9) 0.001
Histology (n, %)
 Adenocarcinoma 151 (56.6) 214 (62.0) 0.178
 Other NSCLCa 101 (37.8) 104 (30.1)
 Small cell 11 (4.1) 17 (4.9)
 other 4 (1.5) 10 (2.9)

a‘other NSCLC’ category includes squamous cell, adenosquamous, large cell and NSCLC not otherwise specified.